News

• 15/01/2021

  The Use of Digital Twins in Healthcare

This report presents the results of a qualitative study into the socio-ethical benefits and socio-ethical risks of using digital twins in healthcare based on the outcome of 23 interviews and 1 expert workshop. -Read more-
• 15/01/2021

  Positioning In Silico Medicine as a computationally-intensive science

In this post, Prof Marco Viceconti calls to arms the in silico medicine community in respect to the scalability grand challenge and its HPC needs. -Read more-
• 03/12/2020

  Stakeholder workshop on the Human Digital Twin organized by the European Commission

On 6 November 2020, a stakeholder workshop on the Human Digital Twin (HDT) was organised by the European Commission. -Read more-
• 03/12/2020

  FDA’s driver of in silico medicine, Tina Morrison, promoted to Director of Regulatory Science and Innovation at FDA

Our long-term collaborator and in silico advocate at FDA, Tina Morrison, has been promoted to Director of Regulatory Science and Innovation -Read more-